Wize Completes Phase 4 Study of LO2A Eye Drops for Sjögren’s; Results Expected Later This Year
A Phase 4 clinical trial evaluating Wize Pharma‘s LO2A eye drops as a treatment for dry eye symptoms in people with Sjögren’s syndrome has been completed, the company announced. Results from the trial are expected later this year, though they may be delayed due to the ongoing…